The tweet was deleted by the author.
But we saved everything 🙂.
Definium Therapeutics has released its financial results for the first quarter of 2026, detailing ongoing progress in its business operations and a strengthened commitment to advancing solutions for mental health disorders.
The company pointed to continuous momentum, emphasizing developments that support its mission to provide hope for individuals facing mental health challenges. Comprehensive financial and business highlights are now accessible to investors and stakeholders.
View post on X Loading...
Definium Therapeutics announced plans to release its first quarter 2026 financial results during a live webcast on May 7. Earlier this year, the company held an Investor and Analyst Day in New York City to update stakeholders on progress in psychedelic treatment development. Both events are part of Definium's ongoing communications with its investor base.